De novo malignancy development following kidney transplantation: Managing risks and outcomes in clinical practice
<i>De novo</i> malignancy remains a concern in kidney transplant recipients, particularly among older patients. Regular screening protocols, lifestyle interventions, and individualized immunosuppressive regimens are essential to mitigate risk and improve outcomes.
Authors
- Amil Hüseynov (ORCID: https://orcid.org/0000-0002-4138-9329)
- Sevim Kuşlu Çiçek (ORCID: https://orcid.org/0000-0003-1581-2573)
Institutions
- Türkisch-Deutsche Universität (TR)
- Biruni University (TR)
- Beykoz Üniversitesi (TR)
Publication Details
- Journal
- Turkish Journal of Surgery
- Published
- 2025-12-08
- DOI
- https://doi.org/10.47717/turkjsurg.2025.2025-4-34
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00